Summary & Overview
Knee Procedures without Principal Diagnosis of Infection without CC/MCC: Inpatient Reimbursement Overview
DRG 489 encompasses inpatient knee procedures without a principal diagnosis of infection and without Major Complication or Comorbidity or Complication or Comorbidity, focusing on cases with lower expected resource use. It matters for inpatient reimbursement because Diagnosis-Related Group assignment drives Medicare hospital payment under the prospective payment system.
DRG 489 Overview
DRG 489 covers inpatient admissions for knee procedures when the principal diagnosis is not an infection and there are no Major Complication or Comorbidity or Complication or Comorbidity present. Typical cases include primary and some revision knee arthroplasty and other operative knee interventions without significant comorbid burden. This Diagnosis-Related Group matters for Medicare payment because it groups similar resource use and sets the prospective payment rate for hospitals. Accurate coding of diagnoses and procedures determines assignment to this Diagnosis-Related Group and the resulting inpatient reimbursement.
Clinical Trials
- Early perioperative analgesia and blood management trials: Studies evaluate multimodal analgesic protocols, regional nerve blocks, and tranexamic acid use in patients undergoing non-infection knee procedures (e.g., total or partial knee arthroplasty, arthroscopic repairs) to reduce intraoperative blood loss, opioid consumption, and immediate postoperative complications. The population typically includes adults admitted for elective or urgent knee surgery without infectious diagnoses, often stratified by age, comorbidity burden, and baseline hemoglobin. Results inform inpatient length of stay, transfusion requirements, and resource utilization, directly impacting provider care pathways and payer reimbursement through effects on LOS and complication-related costs.
- Comparative effectiveness trials of surgical techniques and implants: Randomized or pragmatic comparative studies examine different surgical approaches (e.g., minimally invasive vs standard arthroplasty, cemented vs cementless fixation, or various implant designs) and perioperative protocols in patients receiving knee procedures for degenerative or traumatic indications without infection. These trials focus on functional outcomes, readmission rates, and short-term complication profiles in the acute inpatient period and early rehabilitation phase. Findings help clinicians choose techniques that optimize early recovery and reduce costly readmissions or revisions, which are key drivers of inpatient and post-acute reimbursement for this DRG.
- Post-discharge recovery, rehabilitation, and health-economic outcomes research: Observational cohorts and interventional trials test inpatient-to-outpatient transitional care models, early mobilization protocols, and structured physical therapy regimens for patients discharged after non-infectious knee procedures, including analyses of 30- and 90-day readmissions, functional status, and total episode-of-care costs. These studies often enroll medically complex or older adults who are at higher risk for delayed recovery or discharge to skilled nursing facilities. The evidence helps payers and hospitals design discharge planning and bundled-payment strategies to lower post-acute utilization and improve cost-effectiveness for episodes classified under DRG 489.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.